Q-TWiST may help patients with advanced kidney cancer and their doctors weigh treatment options by focusing on quality of ...

Keeping my part-time teaching job during breast cancer treatment gave me purpose, connection and strength — and it helped me ...

Treatment with Zusduri had a median duration of response of 3.5 years and event-free survival of two years in low-grade ...

IV infiltration and extravasation remind this cancer patient of the constant challenges of speaking up and advocating for ...

Researchers are building on the success of CAR T therapy in blood cancers to explore its use in clear cell renal cell ...

The FDA's Oncologic Drugs Advisory Committee has casted their votes on the utilization of certain treatments in the multiple ...

After attending several cancer support groups, I reflect on what makes them helpful, inclusive and healing — and invite ...

Patients with skin cancer who were fed a high-fiber diet showed better response rates to treatment and longer event-free ...

Quality-of-life in lung cancer varies, with certain treatments leading to sleep-related issues, pain, and emotional changes ...

Butterflies are believed to be a symbol of resurrection and hope. This is an inspiring story about this phenomenon.

FDA grants priority review to TAR-200, which demonstrated an 82% complete response in high-risk bladder cancer unresponsive ...

Dr. Nicholas James shares why it’s important to identify which patients with high-risk, non-metastatic prostate cancer will ...